Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)

Conclusion
Annual CERMRI in HLRCC is cost-effective across age groups modelled.

Source: Journal of Medical Genetics - December 23, 2022 Category: Genetics & Stem Cells Authors: Thompson, A. J., Alwan, Y. M., Ramani, V. A. C., Evans, D. G., Maher, E. R., Woodward, E. R. Tags: Cancer genetics Source Type: research